Skip to main content

Advertisement

Log in

Eosinophilic fasciitis in a pregnant woman with corticosteroid dependence and good response to infliximab

  • Case Based Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Eosinophilic fasciitis (EF) is characterized by symmetrical thickening of subcutaneous muscular fascia, causing skin induration with wrinkles and prominent hair follicles: the classic peau d’orange. Eosinophilia is a characteristic—albeit not universal—finding. We present the case of a 43-year-old pregnant woman diagnosed with EF during pregnancy who had extensive cutaneous involvement and severe functional repercussions, including worsening of lung function and intrauterine growth restriction as a possible complication. Treatment with prednisone was initiated during gestation and it was necessary to increase the dose. After delivery, methotrexate treatment was initiated and the corticosteroid dose progressively decreased, with progressive worsening in the torso and abdomen and secondary dyspnea due to thoracic pressure. Treatment with infliximab was then initiated, with favorable progress, though residual ankle and tarsal joint stiffness and significant muscular atrophy in the limbs continued. The triggering factor of EF was not identified. In a systematic search of the medical literature, three cases of EF in pregnant woman without clear triggers were found. Interestingly, all three cases progressed favorably with steroid treatment. Apart from this case, there are only seven published cases of infliximab use in the literature, all with moderate or complete response. Infliximab could be an option for corticosteroid-dependent EF with no response to other options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Shulman LE (1975) Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 88:70–86

    CAS  PubMed  Google Scholar 

  2. Rodnan GP, Di Bartolomeo A, Medsger TA (1975) Proceedings: EOSINOPHILIC fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome. Arthritis Rheum 18(5):525

    CAS  PubMed  Google Scholar 

  3. Pinal-Fernandez I, Selva O, Callaghan A, Grau JM (2014) Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev 13(4–5):379–382

    CAS  PubMed  Google Scholar 

  4. Ihn H (2019) Eosinophilic fasciitis: from pathophysiology to treatment. Allergol Int 68(4):437–439

    CAS  PubMed  Google Scholar 

  5. Amdur HS, Levin RE (1989) Eosinophilic fasciitis during pregnancy. Obstet Gynecol 73(5 Pt 2):843–847

    CAS  PubMed  Google Scholar 

  6. Strosberg JM (1979) Eosinophilic fasciitis following pregnancy. JAMA 241(20):2144

    CAS  PubMed  Google Scholar 

  7. Fonseca MES, Quaresma MV, Luppino-Assad AP, da Silva HC, Andrade DCO, Sampaio-Barros PD (2018) Eosinophilic fasciitis during pregnancy: case report and review of literature. Rheumatol Int 38(3):525–529

    PubMed  Google Scholar 

  8. Mertens JS, Thurlings RM, Kievit W, Seyger MMB, Radstake TRD, de Jong EMGJ (2017) Long-term outcome of eosinophilic fasciitis: a cross-sectional evaluation of 35 patients. J Am Acad Dermatol 77(3):512-517.e5

    PubMed  Google Scholar 

  9. Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB (1988) Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17(4):221–231

    CAS  PubMed  Google Scholar 

  10. Lebeaux D, Francès C, Barete S, Wechsler B, Dubourg O, Renoux J et al (2012) Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford) 51(3):557–561

    CAS  Google Scholar 

  11. Nassonova VA, Ivanova MM, Akhnazarova VD, Oskilko TG, Bjelle A, Hofer PA et al (1979) Eosinophilic fasciitis. Review and report of six cases. Scand J Rheumatol 8(4):225–233

    CAS  PubMed  Google Scholar 

  12. Killen JW, Swift GL, White RJ (2000) Eosinophilic fasciitis with pulmonary and pleural involvement. Postgrad Med J 76(891):36–37

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Rizzo S (2002) Eosinophilic pleuropericarditis and fasciitis. A new case. Monaldi Arch Chest Dis 57(5–6):311–313

    CAS  PubMed  Google Scholar 

  14. Kirschstein M, Helmchen U, Jensen R, Küster RM, Lehmann H (1999) Kidney involvement in a 17-year-old boy with eosinophilic fasciitis. Clin Nephrol 52(3):183–187

    CAS  PubMed  Google Scholar 

  15. Long H, Zhang G, Wang L, Lu Q (2016) Eosinophilic skin diseases: a comprehensive review. Clin Rev Allergy Immunol 50(2):189–213

    CAS  PubMed  Google Scholar 

  16. Kim HJ, Lee S-W, Kim GJ, Lee J-H (2014) Usefulness of FDG PET/CT in the diagnosis of eosinophilic fasciitis. Clin Nucl Med 39(9):801–802

    PubMed  Google Scholar 

  17. Kissin EY, Garg A, Grayson PC, Dubreuil M, Vradii D, York M et al (2013) Ultrasound assessment of subcutaneous compressibility: a potential adjunctive diagnostic tool in eosinophilic fasciitis. J Clin Rheumatol 19(7):382–385

    PubMed  Google Scholar 

  18. Jinnin M, Yamamoto T, Asano Y, Ishikawa O, Sato S, Takehara K et al (2018) Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis. J Dermatol 45(8):881–890

    PubMed  Google Scholar 

  19. Lebeaux D, Sène D (2012) Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol 26(4):449–458

    CAS  PubMed  Google Scholar 

  20. Nashel J, Steen V (2015) The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis. Clin Rheumatol 34(8):1481–1484

    PubMed  Google Scholar 

  21. Balk EM, Earley A, Avendano EA, Raman G (2016) Long-term health outcomes in women with silicone gel breast implants: a systematic review. Ann Intern Med 164(3):164

    PubMed  Google Scholar 

  22. Kivity S, Katz M, Langevitz P, Eshed I, Olchovski D, Barzilai A (2012) Autoimmune Syndrome Induced by Adjuvants (ASIA) in the Middle East: morphea following silicone implantation. Lupus 21(2):136–139

    CAS  PubMed  Google Scholar 

  23. Blagojevic J, AlOdhaibi KA, Aly AM, Bellando-Randone S, Lepri G, Bruni C et al (2020) Pregnancy in systemic sclerosis: results of a systematic review and metaanalysis. J Rheumatol 47(6):881–887

    PubMed  Google Scholar 

  24. Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA (2016) Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers. JAMA Dermatol 152(1):97–99

    PubMed  Google Scholar 

  25. Mazori DR, Femia AN, Vleugels RA (2017) Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep 19(12):74

    PubMed  Google Scholar 

  26. Endo Y, Tamura A, Matsushima Y, Iwasaki T, Hasegawa M, Nagai Y et al (2007) Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome. Clin Rheumatol 26(9):1445–1451

    PubMed  Google Scholar 

  27. Mertens JS, Zweers MC, Kievit W, Knaapen HKA, Gerritsen M, Radstake TRDJ et al (2016) High-dose intravenous pulse methotrexate in patients with eosinophilic fasciitis. JAMA Dermatol 152(11):1262–1265

    PubMed  Google Scholar 

  28. Tkachenko E, Steuer AB, Lo K, LaChance A, Merola JF, Femia AN et al (2020) Mycophenolate mofetil for eosinophilic fasciitis: a retrospective analysis from 3 tertiary care centers. JAMA Dermatol 15:595

    Google Scholar 

  29. Tull R, Hoover WD, De Luca JF, Huang WW, Jorizzo JL (2018) Eosinophilic fasciitis: a case series with an emphasis on therapy and induction of remission. Drugs Context 7:212529

    PubMed  PubMed Central  Google Scholar 

  30. Loupasakis K, Derk CT (2010) Eosinophilic fasciitis in a pediatric patient. J Clin Rheumatol 16(3):129–131

    PubMed  Google Scholar 

  31. Vílchez-Oya F, Sánchez-Schmidt JM, Agustí A, Pros A (2020) The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review. Clin Rheumatol 39(5):1693–1698

    PubMed  Google Scholar 

  32. Urzal J, Cimbron M, Mendonça T, Farinha F (2019) Eosinophilic fasciitis (Shulman’s disease): review and comparative evaluation of seven patients. Reumatologia 57(2):85–90

    PubMed  PubMed Central  Google Scholar 

  33. Espinoza F, Jorgensen C, Pers Y-M (2015) Efficacy of tocilizumab in the treatment of eosinophilic fasciitis: report of one case. Jt Bone Spine 82(6):460–461

    Google Scholar 

  34. Scheinberg M, Hamerschlak N, Kutner JM, Ribeiro AAF, Ferreira E, Goldenberg J et al (2006) Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002–2004). Clin Exp Rheumatol 24(1):65–69

    CAS  PubMed  Google Scholar 

  35. de Masson A, Bouaziz J-D, de Peffault LR, Benhamou Y, Moluçon-Chabrot C, Bay J-O et al (2013) Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature. Medicine (Baltimore) 92(2):69–81

    Google Scholar 

  36. Nahhas AF, Alam M, Lim HW (2018) Rituximab as a therapeutic consideration for refractory eosinophilic fasciitis. Int J Dermatol 57(5):614–615

    PubMed  Google Scholar 

  37. Kim SR, Charos A, Damsky W, Heald P, Girardi M, King BA (2018) Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib. JAAD Case Rep 4(5):443–445

    PubMed  PubMed Central  Google Scholar 

  38. Cao X-Y, Zhao J-L, Hou Y, Wang F-D, Lu Z-H (2020) Janus kinase inhibitor tofacitinib is a potential therapeutic option for refractory eosinophilic fasciitis. Clin Exp Rheumatol 38(3):567–568

    PubMed  Google Scholar 

  39. Schiener R, Behrens-Williams SC, Gottlöber P, Pillekamp H, Peter RU, Kerscher M (2000) Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy. Br J Dermatol 142(4):804–807

    CAS  PubMed  Google Scholar 

  40. Bischoff L, Derk CT (2008) Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol 47(1):29–35

    PubMed  Google Scholar 

  41. Tkachenko E, Steuer AB, Lo K, Cobos G, Lo Sicco K, Vleugels RA et al (2019) Intravenous immunoglobulin for refractory eosinophilic fasciitis: a retrospective analysis from 3 tertiary care centers. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2019.12.022

    Article  PubMed  Google Scholar 

  42. Pimenta S, Bernardes M, Bernardo A, Brito I, Castro L, Simões-Ventura F (2009) Intravenous immune globulins to treat eosinophilic fasciitis: a case report. Jt Bone Spine 76(5):572–574

    Google Scholar 

  43. Bonnotte B, Chauffert B, Caillot D, Martin F, Lorcerie B (1998) Successful treatment with antithymocyte globulin and cyclosporin A of a severe aplastic anaemia associated with an eosinophilic fasciitis. Br J Rheumatol 37(12):1358–1359

    CAS  PubMed  Google Scholar 

  44. Caspi D, Fishel R, Varon M, Yona E, Baratz M, Yaron M (1982) Multisystem presentation of eosinophilic fasciitis. Rheumatol Rehabil 21(4):218–221

    CAS  PubMed  Google Scholar 

  45. Jones AC, Doherty M (1993) Eosinophilic fasciitis with late onset arthritis responsive to sulfasalazine. J Rheumatol 20(4):750–751

    CAS  PubMed  Google Scholar 

  46. Oza VS, Walsh R, North J, Berger TG, Murase JE (2016) Treatment of eosinophilic fasciitis with sirolimus. JAMA Dermatol 152(4):488–490

    PubMed  Google Scholar 

  47. Mendoza FA, Bai R, Kebede AG, Jimenez SA (2016) Severe eosinophilic fasciitis: comparison of treatment with D-penicillamine plus corticosteroids vs. corticosteroids alone. Scand J Rheumatol 45(2):129–134

    CAS  PubMed  Google Scholar 

  48. Manzini CU, Sebastiani M, Giuggioli D, Manfredi A, Colaci M, Cesinaro AM et al (2012) D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. Clin Rheumatol 31(1):183–187

    CAS  PubMed  Google Scholar 

  49. Suzuki G, Itoh Y, Horiuchi Y (1997) Surgical management of eosinophilic fasciitis of the upper extremity. J Hand Surg Br 22(3):405–407

    CAS  PubMed  Google Scholar 

  50. Neumeister MW, Robertson GA (1998) Therapeutic fasciectomy for eosinophilic fasciitis. Ann Plast Surg 41(2):208–210

    CAS  PubMed  Google Scholar 

  51. Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA (2003) Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 7(5):382–386

    PubMed  Google Scholar 

  52. Khanna D, Agrawal H, Clements PJ (2010) Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases. Rheumatology (Oxford) 49(6):1184–1188

    Google Scholar 

  53. Poliak N, Orange JS, Pawel BR, Weiss PF (2011) Eosinophilic fasciitis mimicking angioedema and treatment response to infliximab in a pediatric patient. Ann Allergy Asthma Immunol 106(5):444–445

    PubMed  Google Scholar 

  54. Tzaribachev N, Holzer U, Schedel J, Maier V, Klein R, Kuemmerle-Deschner J (2008) Infliximab effective in steroid-dependent juvenile eosinophilic fasciitis. Rheumatology (Oxford) 47(6):930–932

    CAS  Google Scholar 

  55. Yamamoto T, Ito T, Asano Y, Sato S, Motegi S, Ishikawa O et al (2020) Characteristics of Japanese patients with eosinophilic fasciitis: a brief multicenter study. J Dermatol 47:1391–1394

    CAS  PubMed  Google Scholar 

Download references

Funding

No funding was received.

Author information

Authors and Affiliations

Authors

Contributions

All the authors whose names appear on the submission: (1) made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; (2) drafted the work or revised it critically for important intellectual content; (3) approved the version to be published; and (4) agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Nicolás Jiménez-García.

Ethics declarations

Conflict of interest

All the authors declare that they have no conflict of interest.

Ethical approval (Include appropriate approvals or waivers)

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiménez-García, N., Aguilar-García, J., Fernández-Canedo, I. et al. Eosinophilic fasciitis in a pregnant woman with corticosteroid dependence and good response to infliximab. Rheumatol Int 41, 1531–1539 (2021). https://doi.org/10.1007/s00296-021-04787-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04787-6

Keywords

Navigation